Oct 25, 2017 | By Tess

German chemicals company BASF has signed an agreement with French biotech firm Poietis to continue developing services and products in the 3D bioprinting field.

The two companies, which have been collaborating for the past two years on cosmetics-related research, will be focusing their bioprinting efforts on the improvement of laser-assisted, bioprinted skin models which could have applications in the cosmetics sector.

According to the companies, their goal is to apply their joint 3D bioprinted skin project for the testing and evaluating of cosmetic ingredients and skin care products.

As Fabien Guillemot, founder and president of Poietis, explained: “Bioprinted 3D models are the method of choice for the predictive evaluation of ingredients as these models reproduce the cell environment in vitro by having mechanical and metabolic functionalities close to the vivo.”

The bioprinting technology used to create the artificial skin uses a laser-assisted method which builds up skin cells into different 3D structures. The innovative process has allowed BASF and Poietis to produce “fully printed skin equivalents” in just a couple of weeks, further opening the doors for ethical cosmetics testing as well as new and innovative skin care products.

Sebastien Cadau, head of tissue engineering development at BASF, added: “During our cooperation, we gained important insights like the parameters and kinetics of dermis maturation. A mature and thick dermis is an essential condition to obtain optimum results in epidermal printing.”

Through the first years of their collaboration, BASF and Poietis successfully developed a bioprinting technology that could automatically reproduce the former’s Mimeskin, which is apparently one of the “closest equivalents to the original physiological tissue of human skin.”

Poietis' laser-assisted 3D bioprinter

Now, through their renewed agreement, the two European companies will continue their efforts in the hopes of refining the technology as well as the skin models. Cadau explains that this will involve increasing the complexity of the skin cell structures and experimenting with new cell types.

“This agreement confirms a fruitful scientific collaboration and strengthens our partnership with the leading ingredients manufacturer for the personal care market,” added Bruno Brisson, co-founder and vice president of business development at Poietis. “This is a formal recognition of Poietis' unique technology and its valorization driven by new developments since the creation of the company.”

BASF’s ultimate goal is to leverage the skin 3D bioprinting technology to bring to market new active ingredients for the cosmetics industry. The company recently showcased the potential of the technology with the presentation of Dermagenist™, its first active ingredient tested and confirmed using the jointly developed laser-assisted bioprinted skin models.



Posted in 3D Printing Application



Maybe you also like:


Poietis wrote at 10/26/2017 11:59:21 AM:

Dear Tess, thank you very much for sharing information about our company but please update the logotype and the printer picture! http://poietis.com/en/media.php

Leave a comment:

Your Name:


Subscribe us to

3ders.org Feeds 3ders.org twitter 3ders.org facebook   

About 3Ders.org

3Ders.org provides the latest news about 3D printing technology and 3D printers. We are now seven years old and have around 1.5 million unique visitors per month.

News Archive